1Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology,2001;108:449-460
2Avisar R, Dan DG, Nisinl L, Itiel A, Dov W. Intraoperative mitomycin C 0.02% for pterygium-effect of during of application on recurrence rate.Cornea, 2003;22:102-104
3Gaidera AC, Luchs JI, Vdell IS. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology,2001;108:936-944
4Kintworth GK. Chronic Keratopath: a condition associated with conjunctival elatosis (pinguecula) and typified by characteristic extracellular concretion.Am J Pathol, 1992;67:372
5Rubinfeld RS, Pfister RR, Stein RM. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology, 1992;99(11):1647-1654
6Kunitomo N, Mori S. Studies on the pterygia: part V. Acta Ophthalmol Jpn,1963;67:601-607
7Cardillo JA, Alves MR, Ambrosio LE, Poterio MB, Jose NK. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology, 1995;102(12):1949-1952
3Sack RA,Beaton AR,Sathe S.Diurnal variations in angiostatin in human tear fluid:A possible role in prevention of corneal neovascularization.Current Eye Research1999;18(3):186-193.
4Kim JH,Kim JC,Shin SH,et al.The inhibitory effects of recombinant plasogen kringle1-3 on the neovascularization of rabbit cornea induced by angiogenin,BFGF and VEGF.Exp Mol Med1999;31(4):203-209.
